NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Care Facilities · USD

COMPASS Pathways plc (CMPS) Stock Analysis

COMPASS Pathways plc (CMPS) is a Medical Care Facilities stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

CMPS

$11.84

−$0.06 (−0.50%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CMPS with… →

CMPS Key Statistics

As of Oct 21, 2026
Trading
Open
$12.00
Previous Close
$11.90
Day's Range
11.77–12.12
52-Week Range
4.88–15.87
Volume
1.83M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
2.56
Valuation
Market Cap
$1.56B
P/E Ratio
unprofitable
EPS (ttm)Profit attributable to each share over the last twelve months.
−3.76
Financials (FY)
Revenue (FY)
$0.00
Net Income (FY)
−$287.86M
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
138.48M
1-Year Return
+82.15%
Dividend and dates
Earnings Date
November 3, 2026
Avg Volume
2.97M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, CMPS closed at $11.84, +82.15% over 1 year.

COMPASS Pathways plc (CMPS) has a market capitalization of $1.56B.

In fiscal 2025, CMPS reported revenue of $0.00.

CMPS Stock Return by Calendar Year

COMPASS Pathways plc (CMPS) return since Sep 2020: what $10,000 became

1 year
$10,000 $18,215
+82.15%
5 years
$10,000 $3,353
−66.47%
Since Sep 2020
$10,000 $4,083
−59.17%

If you had invested $10,000 in COMPASS Pathways plc (CMPS) at the close on September 18, 2020, the earliest close on record here, it would have been worth $4,083 at the close on October 21, 2026: −59.17% in total, −13.68% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+71.59%
2025+82.54%
2024−56.80%
2023+8.97%
2022−63.67%
2021−53.61%
2020 (partial year)+64.28%

As of October 21, 2026.

CMPS Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$0.00−$287.86M—
2024$0.00−$155.12M—
2023$0.00−$118.46M—
2022$0.00−$91.51M—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$0.00—−$175.29M−$287.86M—
2024$0.00—−$157.11M−$155.12M—
2023$0.00—−$124.04M−$118.46M—
2022$0.00—−$95.98M−$91.51M—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

COMPASS Pathways plc (CMPS) carries a market capitalisation of $1.56B. It is classified in the Medical Care Facilities industry, within the Healthcare sector. The company reports 156 employees.

The most recent close on file for CMPS is $11.84, dated October 21, 2026. That is −$0.06 (−0.50%) against the previous close. Over the past 52 weeks the price has ranged from $4.88 to $15.87. The latest close sits 142.62% above that 52-week low.

Financial Health

In fiscal 2025, COMPASS Pathways plc reported revenue of $0.00. The same year closed with a net loss of $287.86M. Earnings per share on a trailing basis come to −3.76.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $0.00 in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative.

Over the trailing twelve months the total return is +82.15%. Measured over 5 years, that is −19.63% a year compounded. Beta against the wider market is reported at 2.56. Daily returns over the trailing 6 years annualize to a volatility of 79.37%.

Growth & Income

The record shows no dividend for CMPS.

Across the complete calendar years on file, 2025 returned +82.54% and 2022 returned −63.67%. Of the 5 complete calendar years on file, 2 finished higher. So far in 2026 the total return is +71.59%.

Peer Comparison

COMPASS Pathways plc (CMPS) operates in the Medical Care Facilities industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
COMPASS Pathways plc CMPS $1.56B —
HCA Healthcare, Inc. HCA $99.46B 15.4
Tenet Healthcare Corporation THC $21.67B 10.6
Encompass Health Corporation EHC $11.88B 20.2

The Medical Care Facilities industry average P/E ratio is 20.7x. COMPASS Pathways plc has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Care Facilities Stocks

HCA

HCA Healthcare, Inc.

$99.46B

 THC

Tenet Healthcare Corporation

$21.67B

 EHC

Encompass Health Corporation

$11.88B

 FMS

Fresenius Medical Care AG

$11.47B

 DVA

DaVita Inc.

$11.28B

 UHS

Universal Health Services, Inc.

$10.78B
View all Medical Care Facilities stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About COMPASS Pathways plc

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

Visit website →